Sudomotor Dysfunction and the Rising Tide of Diabetes: Spotlight on the Indicator Plaster Method

Diabetic peripheral neuropathy (DPN) is among the most common and insidious complications of diabetes, affecting both the quality and longevity of life. One of the earliest and most overlooked signs of DPN is sudomotor dysfunction — the impairment of sweat gland regulation due to autonomic nerve damage. This disruption in sweating leads to dry, cracked skin, especially on the feet, creating a gateway to infections and foot ulcers.

Traditionally, diagnosing sudomotor dysfunction required costly or specialist tools, limiting early detection. However, the Indicator Plaster Method (IPM) has emerged as a revolutionary, patient-friendly tool for identifying early signs of autonomic nerve damage. This study by Wang et al. sought to validate the IPM’s effectiveness across a range of glycemic states — from normal glucose tolerance through prediabetes to overt diabetes.

Background

Neuropathy can appear even in people with prediabetes, often without symptoms. Small unmyelinated C-fibres — which innervate the sweat glands — are among the first to be damaged. This makes sweat gland function a sensitive early indicator of nerve damage. Sudomotor dysfunction can occur before blood sugar is high enough to qualify for a diabetes diagnosis, placing many patients at risk before they or their clinicians are even aware.

The IPM is a simple adhesive patch applied to the sole of the foot. A healthy foot with adequate sweat production will cause the patch to change colour from blue to pink within ten minutes. A failure to change colour is a red flag for sudomotor dysfunction. What makes this method particularly valuable is its low cost, ease of use, and capacity for both visual and quantitative analysis, especially when paired with a handheld colour analyser.

Methods

This cross-sectional study recruited 481 adults in China undergoing routine physical exams, with glycemic statuses ranging from normal to previously diagnosed diabetes. Participants were divided into four groups: normoglycaemia, prediabetes, newly diagnosed diabetes, and previously diagnosed diabetes.

IPM testing was conducted under controlled environmental conditions. The test strips were placed near the metatarsal heads, and colour change was assessed visually and with handheld colour analysers. The rate of colour change (slope) over 10 minutes served as a quantitative proxy for sudomotor function: the faster the change, the healthier the nerve function.

Researchers also measured an array of clinical and biochemical indicators — including fasting glucose, HbA1c, BMI, kidney and liver function — to adjust for confounders and to explore other factors that might influence sweat gland performance.

Findings

The results were unequivocal: sudomotor function progressively declined with worsening glycemic control.

Participants with previously diagnosed diabetes showed:

  • The slowest rate of colour change (mean slope 6.96 vs. 8.73 in the normoglycaemia group)
  • The highest rate of incomplete colour change (71.1% vs. 49.0% in the normoglycaemia group)

Multivariable models confirmed that previously diagnosed diabetes was an independent predictor of impaired sudomotor function, even after adjusting for age, BMI, kidney function, and alcohol history. Interestingly, while prediabetes and newly diagnosed diabetes also showed declining trends, the differences were not statistically significant compared to normoglycaemic individuals. This suggests that damage may accumulate more subtly in earlier stages, or that longer duration of dysglycaemia plays a larger role.

Beyond glycemic control, several other factors were significantly linked to sudomotor dysfunction:

  • Age: Older individuals showed reduced sweat response.
  • Lower albumin: Possibly reflecting poorer nutritional or health status, also linked to reduced function.
  • Low eGFR (impaired kidney function) and history of alcohol consumption were also associated with worse sudomotor performance.

Why the IPM Deserves Attention

The Indicator Plaster Method (IPM) test — both in its traditional visual format and its enhanced quantitative version — proved to be a sensitive, non-invasive, and affordable tool for assessing early nerve dysfunction in this study.

The Indicator Plaster Method (IPM) test:

  • Requires no specialist equipment
  • Can be used at the bedside or even at home
  • Shows good repeatability and reliability
  • Is ideal for widespread screening in both clinical and community settings

Its particular strength lies in detecting small fibre neuropathy, which typically precedes large fibre damage and gross motor or sensory symptoms. Thus, the IPM offers a crucial opportunity for early intervention, ideally before irreversible complications like foot ulcers develop.

Conclusion

This study underscores the pressing need to incorporate sudomotor testing — and specifically the Indicator Plaster Method — into routine diabetes care. It detected significant sudomotor dysfunction in patients with diabetes and highlighted a troubling prevalence even among people with prediabetes or normal blood glucose. As hyperglycaemia persists over time, the decline in sweat gland function becomes more pronounced, increasing the risk of downstream complications.

Given its low cost, high sensitivity, and simplicity, the IPM should be widely adopted in screening protocols for diabetic autonomic neuropathy. Early detection allows for earlier lifestyle or medical interventions, potentially halting the march toward foot ulcers, amputations, and other devastating consequences of untreated DPN.

In a world facing a diabetes epidemic, the humble colour-changing plaster may prove to be one of our most powerful frontline tools.